Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Capital Expenditures (2020 - 2023)

Historic Capital Expenditures for Journey Medical (DERM) over the last 3 years, with Q1 2023 value amounting to $5.0 million.

  • Journey Medical's Capital Expenditures fell 7500.0% to $5.0 million in Q1 2023 from the same period last year, while for Dec 2023 it was $5.0 million, marking a year-over-year decrease of 7500.0%. This contributed to the annual value of $15.0 million for FY2024, which is 20000.0% up from last year.
  • Per Journey Medical's latest filing, its Capital Expenditures stood at $5.0 million for Q1 2023, which was down 7500.0% from $20.0 million recorded in Q1 2022.
  • Over the past 5 years, Journey Medical's Capital Expenditures peaked at $20.0 million during Q1 2022, and registered a low of $4.1 million during Q4 2020.
  • Its 3-year average for Capital Expenditures is $9.7 million, with a median of $5.0 million in 2023.
  • Examining YoY changes over the last 5 years, Journey Medical's Capital Expenditures showed a top increase of 7500.0% in 2023 and a maximum decrease of 7500.0% in 2023.
  • Quarter analysis of 3 years shows Journey Medical's Capital Expenditures stood at $4.1 million in 2020, then soared by 382.51% to $20.0 million in 2022, then plummeted by 75.0% to $5.0 million in 2023.
  • Its Capital Expenditures was $5.0 million in Q1 2023, compared to $20.0 million in Q1 2022 and $4.1 million in Q4 2020.